It is generally agreed that tumors are composed of multiple cell clones defined by 2 different somatic mutations. Characterizing the evolutionary mechanisms driving 3 this intratumor genetic heterogeneity (ITH) is crucial to improve both cancer 4 diagnosis and therapeutic strategies. For that purpose, recent ITH studies have 5 focused on qualitative comparisons of mutational profiles derived from bulk 6 sequencing of multiple tumor samples extracted from the same patient. Here, we 7
52
16 . 53 54 However, although a variety of statistical algorithms exist to infer the clonal 55 composition of tumors from bulk NGS data (see Beerenwinkel et al. 17 
Mutational histories 95
Since most tumors consist of a genetically heterogeneous population of cells, (Fig. 1C, Supplementary Note) . 134 ( Fig. 2A) , but for which a distinct set of regional samples was obtained (Fig. 2B) . 137
In this case, the use of mutational profiles results in a phylogenetic tree in which 138
mutation 5 spuriously appears to have occurred twice, independently in sample 139 II and III. Again, the use of a clustering algorithm for clonal identification avoids 140 this type of bias, leading to the inference of the true tree and the true mutational 141 history (Fig. 2C) . 142 143 Furthermore, the fact that different sets of samples obtained from the same 144 primary tumor can generate two distinct, and incorrect, evolutionary histories 145 (Fig. 1B and Fig. 2B) suggests that phylogenetic analysis of mutational profiles 146 from bulk tumor tissues can be less straightforward than previously thought. 147
148

Relative timing of metastasis 149
Another potential issue associated with the use of composite clones is 150 determining the evolutionary relationships between the primary tumor and distant 151 metastases. Following a similar approach to Zhao et al. 19 , consider now a patient 152 for which four distinct samples have been sequenced: a primary tumor sample 153 and three metastases (Fig. 3A) . For simplicity, we assume that (i) there is no 154 contamination from healthy cells, (ii) only the primary tumor hosts several clones, 155 and (iii) somatic mutations accumulate linearly with time (i.e., following a 156 molecular clock). In this example, there are four true clones (A-D). Clone A 157 represents the ancestral lineage from which the other clones derived. Clone B, 158 which was never sampled/existed in the primary tumor, represents the first 159 metastasis (metastasis I), followed by migration of clone C (metastasis II) and 160 later of clone D (metastasis III) into three distinct anatomical regions (Fig. 3B,  161 
right-panel). 162 163
By assuming that a single clone occurs (or dominates) in each sample, as in Zhao 164 et al. 19 , the primary tumor would be represented by a composite clone that never 165 existed (Fig. 3C, left-panel) . In consequence, if we reconstruct a MP tree from 166 these data we will wrongly infer that metastasis II occurred before metastasis I -167 because in this case the lineage leading to metastasis II diverges before the 168 lineage leading to metastasis I -and that mutations 4 and 5 evolved in parallel inthe primary tumor and in metastasis II (Fig. 3C, right-panel) . Moreover, because 170 the composite clone for the primary tumor carries all mutations it is tempting to 171 conclude that it represents the youngest clone (perhaps resulting from a recent 172 selective sweep) when in fact is the oldest lineage. Conversely, if we use the 173 observed VAFs to deconvolute the clones present in each sample, despite clone 174
A not being identified by the clustering algorithm (Fig. 3D, left-panel) , we will infer 175 a phylogenetic tree that accurately represents the evolutionary history of this 176 cancer (Fig. 3D, right-panel) . 177
179
Analysis of real data 180
Since the examples above represent speculative scenarios, we reanalysed three 181 multiregional datasets in order to understand whether the use of mutational 182
profiles versus the use of inferred clones can also lead to different conclusions in 183 real scenarios. In the first study, Hao et al. 16 investigated the spatial distribution 184 of ITH in esophageal squamous cell carcinoma. Using mutational profiles, the 185 authors reconstructed sample trees for several patients and found multiple cases 186 where mutations were "incompatible" with the inferred tree. Interestingly, these 187 are precisely those (parallel) mutations that appear more than once 188 (Supplementary Fig.2A) . Conversely, when we inferred the clones present in 189 the samples and reconstructed their history, all parallel changes disappeared 190 (Supplementary Fig.2B ). We argue that in fact the latter scenario seems much 191 more plausible. .3A) , a clonal analysis points instead to the presence of four clonal lineages 198 segregating at different frequencies across the regional samples with substantial 199 spatial overlap (Supplementary Fig.3B) . two samples (R3 and R9) and the inferred MP tree suggested five instances of 211 parallel evolution at the FAM110B, TSKU, TPRG1, NOP2 and BAP1 genes, the 212 latter being a tumor suppressor gene identified as a putative driver 213 (Supplementary Fig.4A) . In contrast, a joint formal analysis of the VAFs of all 214 regional samples suggests an alternative evolutionary scenario, with three clonal 215
lineages showing an uneven distribution across the different subsections of the 216 tumor (Supplementary Fig.4B) . Notably, the clonal tree implies a single parallel 217 mutation at the FAM110B gene. 
